Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
FDA Approves Targeted Immunotherapy for Adults with Follicular Lymphoma
“Although we are making great progress in treating follicular lymphoma, it remains incurable, and we need new treatments like epcoritamab in this chem…
News
FDA Approves New Drug to Treat Advanced AML in Adults
Blood Cancer United® funding supported menin inhibitor drugs, including ziftomenib, at every stage of scientific development.
News
New Guide Pulls Back the Curtain on U.S. Hospital Financing and Operations
“What to Ask (About) a Hospital” provides policymakers, journalists, advocates and patients with an ‘all-you-need-to-know’ guide to understanding hosp…
News
Newly Approved Treatment Slows Progression to Multiple Myeloma
Latest treatment holds off progression to multiple myeloma in people with a high-risk precursor condition
News
FDA Expands Drug’s Approval To Include More People With AML
Blood Cancer United funding supported discovery and development of breakthrough menin inhibitors.
News
FDA Approves Drug for People With Advanced Disease Multiple Myeloma
Belantamab mafodotin (Blenrep) in a three-drug combination is now approved for the treatment of relapsed/refractory multiple myeloma.
News
Where Your Ancestors Came From Can Influence Blood Cancer Survival Rates
Scientists are learning more every day about how mutations in an individual's genes can affect their health. But now we’re learning that differences i…
News
TAP Biotech Partner ImCheck Therapeutics to be Acquired by Ipsen in €1B deal
Ipsen and ImCheck Therapeutics announced they have entered into a definitive agreement in which Ipsen will acquire ImCheck Therapeutics, a private Fre…
News
Clear Channel Outdoor and Blood Cancer United Team Up on Billboard Campaign to Reach More People Affected by Blood Cancer
Out-of-Home Campaign Introduces The Leukemia & Lymphoma Society’s New Name, Blood Cancer United, to Engage More Communities and Increase Awareness of …
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
